Frazier Life Sciences Management, L.P
$3.9B Assets Reported
43 Holdings
Latest filing 2026-03-31
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| MIRM | MIRUM PHARMACEUTICALS INC | 7,679,684 | $709M | 18.3% |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 16,943,774 | $542M | 14.0% |
| ERAS | ERASCA INC | 24,675,188 | $399M | 10.3% |
| BBIO | BRIDGEBIO PHARMA INC | 3,448,139 | $256M | 6.6% |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 9,874,511 | $233M | 6.0% |
| MBX | MBX BIOSCIENCES INC | 6,652,013 | $199M | 5.1% |
| PHAT | PHATHOM PHARMACEUTICALS INC | 12,466,489 | $139M | 3.6% |
| MAZE | MAZE THERAPEUTICS INC | 4,567,274 | $136M | 3.5% |
| KRYS | KRYSTAL BIOTECH INC | 481,307 | $124M | 3.2% |
| TRVI | TREVI THERAPEUTICS INC | 9,939,547 | $119M | 3.1% |
Track Frazier Life Sciences Management, L.P's 13F portfolio: $3.9B in reported holdings, 43 positions. Top holdings, AUM, and quarterly changes on SentiSense.